Colloids and crystalloids: Does it matter to the kidney?

Current Opinion in Critical Care

Volumn 15, Issue 6, 2009, Pages 520-524

  Roche, Anthony M ^a   James, Michael F ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Acute kidney injury; Colloid; Crystalloid; Fluids (intravenous)

Indexed keywords

CONTRAST MEDIUM;

ACID BASE BALANCE; ALKALINIZATION; COLLOID; CONTRAST INDUCED NEPHROPATHY; CRITICALLY ILL PATIENT; CRYSTALLOID; FLUID BALANCE; HUMAN; HYDRATION; KIDNEY FAILURE; KIDNEY INJURY; REVIEW;

COLLOIDS; CRITICAL ILLNESS; FLUID THERAPY; HUMANS; ISOTONIC SOLUTIONS; KIDNEY; KIDNEY FAILURE, ACUTE;

EID: 74949108695     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0b013e328332f686     Document Type: Review

References (40)

1. Kellum JA, Cerda J, Kaplan LJ, et al. Fluids for prevention and management of acute kidney injury. Int J Artif Organs 2008; 31:96-110.
2. Townsend DR, Bagshaw SM. New insights on intravenous fluids, diuretics and acute kidney injury. Nephron Clin Pract 2008; 109:c206-c216.
3. Venkataraman R, Kellum JA. Prevention of acute renal failure. Chest 2007; 131:300-308.
4. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345:1368-1377.
5. Wiedemann HP, Wheeler AP, Bernard GR, et al. Comparison of two fluidmanagement strategies in acute lung injury. N Engl J Med 2006; 354:2564-2575.
6. Sakr Y, Vincent JL, Reinhart K, et al. High tidal volume and positive fluid balance are associated with worse outcome in acute lung injury. Chest 2005; 128:3098-3108.
7. Van Biesen W, Yegenaga I, Vanholder R, et al. Relationship between fluid status and its management on acute renal failure (ARF) in intensive care unit (ICU) patients with sepsis: a prospective analysis. J Nephrol 2005; 18:54-60.
8. Foland JA, Fortenberry JD, Warshaw BL, et al. Fluid overload before continuous hemofiltration and survival in critically ill children: a retrospective analysis. Crit Care Med 2004; 32:1771-1776.
9. Fencl V, Leith DE. Stewart's quantitative acid-base chemistry: applications in biology and medicine. Respir Physiol 1993; 91:1-16.
10. Stewart PA. How to understand acid-base. New York: Elsevier; 1981.
11. Stewart PA. Modern quantitative acid-base chemistry. Can J Physiol Pharmacol 1983; 61:1444-1461.
12. Wilcox CS. Regulation of renal blood flow by plasma chloride. J Clin Invest 1983; 71:726-735.
13. Scheingraber S, Rehm M, Sehmisch C, Finsterer U. Rapid saline infusion produces hyperchloremic acidosis in patients undergoing gynecologic surgery. Anesthesiology 1999; 90:1265-1270.
14. Waters JH, Gottlieb A, Schoenwald P, et al. Normal saline versus lactated Ringer's solution for intraoperative fluid management in patients undergoing abdominal aortic aneurysm repair: an outcome study. Anesth Analg 2001; 93:817-822.
15. Wilkes NJ, Woolf R, Mutch M, et al. The effects of balanced versus salinebased hetastarch and crystalloid solutions on acid-base and electrolyte status and gastric mucosal perfusion in elderly surgical patients. Anesth Analg 2001; 93:811-816.
16. Williams EL, Hildebrand KL, McCormick SA, Bedel MJ. The effect of intravenous lactated Ringer's solution versus 0.9% sodium chloride solution on serum osmolality in human volunteers. Anesth Analg 1999; 88:999-1003.
17. Gan TJ, Bennett-Guerrero E, Phillips-Bute B, et al. Hextend, a physiologically balanced plasma expander for large volume use in major surgery: a randomized phase III clinical trial. Hextend Study Group. Anesth Analg 1999; 88:992-998.
18. O'Malley CM, Frumento RJ, Hardy MA, et al. A randomized, double-blind comparison of lactated Ringer's solution and 0.9% NaCl during renal transplantation. Anesth Analg 2005; 100:1518-1524.
19. Khajavi MR, Etezadi F, Moharari RS, et al. Effects of normal saline vs. lactated ringer's during renal transplantation. Ren Fail 2008; 30:535-539.
20. Goldenberg I, Matetzky S. Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies. CMAJ 2005; 172:1461-1471.
21. Aspelin P, Aubry P, Fransson SG, et al. Nephrotoxic effects in highrisk patients undergoing angiography. N Engl J Med 2003; 348:491-499.
22. Solomon R. The role of osmolality in the incidence of contrast-induced nephropathy: a systematic review of angiographic contrast media in high risk patients. Kidney Int 2005; 68:2256-2263.
23. Merten GJ, Burgess WP, Gray LV, et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA 2004; 291:2328-2334.
24. Navaneethan SD, Singh S, Appasamy S, et al. Sodium bicarbonate therapy for prevention of contrast-induced nephropathy: a systematic review and metaanalysis. Am J Kidney Dis 2009; 53:617-627.
25. Meier P, Ko DT, Tamura A, et al. Sodium bicarbonate-based hydration prevents contrast-induced nephropathy: a meta-analysis. BMC Med 2009; 7:23.
26. Haase M, Haase-Fielitz A, Bellomo R, et al. Sodium bicarbonate to prevent increases in serum creatinine after cardiac surgery: a pilot double-blind, randomized controlled trial. Crit Care Med 2009; 37:39-47.
27. Biesenbach G, Kaiser W, Zazgornik J. Incidence of acute oligoanuric renal failure in dextran 40 treated patients with acute ischemic stroke stage III or IV. Ren Fail 1997; 19:69-75.
28. Matheson NA, Diomi P. Renal failure after the administration of dextran 40. Surg Gynecol Obstet 1970; 131:661-668.
29. Diomi P, Ericsson JL, Matheson NA, Shearer JR. Studies on renal tubular morphology and toxicity after large doses of dextran 40 in the rabbit. Lab Invest 1970; 22:355-360.
30. Mailloux L, Swartz CD, Capizzi R, et al. Acute renal failure after administration of low-molecular weight dextran. N Engl J Med 1967; 277:1113-1118.
31. Moran M, Kapsner C. Acute renal failure associated with elevated plasma oncotic pressure. N Engl J Med 1987; 317:150-153.
32. Legendre C, Thervet E, Page B, et al. Hydroxyethyl starch and osmoticnephrosis- like lesions in kidney transplantation. Lancet 1993; 342:248-249.
33. Schortgen F, Lacherade JC, Bruneel F, et al. Effects of hydroxyethyl starch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet 2001; 357:911-916.
34. Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008; 358:125-139.
35. Boldt J, Priebe HJ. Intravascular volume replacement therapy with synthetic colloids: is there an influence on renal function? Anesth Analg 2003; 96:376-382.
36. Neff TA, Doelberg M, Jungheinrich C, et al. Repetitive large-dose infusion of the novel hydroxyethyl starch 130/0.4 in patients with severe head injury. Anesth Analg 2003; 96:1453-1459.
37. Boldt J, Brosch C, Ducke M, et al. Influence of volume therapy with a modern hydroxyethyl starch preparation on kidney function in cardiac surgery patients with compromised renal function: a comparison with human albumin. Crit Care Med 2007; 35:2740-2746.
38. Mahmood A, Gosling P, Vohra RK. Randomized clinical trial comparing the effects on renal function of hydroxyethyl starch or gelatine during aortic aneurysm surgery. Br J Surg 2007; 94:427-433.
39. Sakr Y, Payen D, Reinhart K, et al. Effects of hydroxyethyl starch administration on renal function in critically ill patients. Br J Anaesth 2007; 98:216-224.
40. Schortgen F, Girou E, Deye N, Brochard L. The risk associated with hyperoncotic colloids in patients with shock. Intensive Care Med 2008; 34:2157-2168.